0000947871-14-000532.txt : 20140818 0000947871-14-000532.hdr.sgml : 20140818 20140818190358 ACCESSION NUMBER: 0000947871-14-000532 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140814 FILED AS OF DATE: 20140818 DATE AS OF CHANGE: 20140818 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WebMD Health Corp. CENTRAL INDEX KEY: 0001326583 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 202783228 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 EIGHTH AVE. CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: 212-624-3700 MAIL ADDRESS: STREET 1: 111 EIGHTH AVE. CITY: NEW YORK STATE: NY ZIP: 10011 FORMER COMPANY: FORMER CONFORMED NAME: WebMD Health Holdings, Inc. DATE OF NAME CHANGE: 20050510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Anevski Peter CENTRAL INDEX KEY: 0001576147 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35337 FILM NUMBER: 141050284 MAIL ADDRESS: STREET 1: C/O WEBMD HEALTH CORP. STREET 2: 111 EIGHTH AVENUE CITY: NEW YORK STATE: NY ZIP: 92067 4 1 ss400877_4.xml OWNERSHIP DOCUMENT X0306 4 2014-08-14 0 0001326583 WebMD Health Corp. WBMD 0001576147 Anevski Peter 111 EIGHTH AVENUE NEW YORK NY 10011 0 1 0 0 Exec VP and CFO Common Stock 2014-08-14 4 S 0 15000 47.60 D 54546 D Common Stock 2014-08-15 4 M 0 30000 23.61 A 84546 D Common Stock 2014-08-15 4 F 0 22588 48.20 D 61958 D Common Stock 2014-08-15 4 M 0 22500 22.40 A 84458 D Common Stock 2014-08-15 4 F 0 16669 48.19 D 67789 D Common Stock 2014-08-15 4 M 0 32500 13.15 A 100289 D Common Stock 2014-08-15 4 F 0 21056 48.19 D 79233 D Common Stock 2014-08-15 4 S 0 25000 48.02 D 54233 D Common Stock 202 I By 401(k) Plan Stock Option (Right to Buy) 23.61 2014-08-15 4 M 0 30000 0 D 2018-12-10 Common Stock 30000 3000 D Stock Option (Right to Buy) 22.40 2014-08-15 4 M 0 22500 0 D 2022-05-21 Common Stock 22500 22500 D Stock Option (Right to Buy) 13.15 2014-08-15 4 M 0 32500 0 D 2022-11-14 Common Stock 32500 32500 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.60 to $47.64 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Mr. Anevski received 7,412 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 30,000 shares of WebMD Common Stock, with the remaining 22,588 shares being retained by the issuer to pay the exercise price and to satisfy the minimum tax withholding requirements arising from the exercise. Mr. Anevski received 5,831 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 22,500 shares of WebMD Common Stock, with the remaining 16,669 shares being retained by the issuer to pay the exercise price and to satisfy the minimum tax withholding requirements arising from the exercise. Mr. Anevski received 11,444 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 32,500 shares of WebMD Common Stock, with the remaining 21,056 shares being retained by the issuer to pay the exercise price and to satisfy the minimum tax withholding requirements arising from the exercise. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.68 to $48.11 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4. 25% of the shares underlying the option vested on each of 3/31/2010, 3/31/2011, 3/31/2012 and 3/31/2013 (fully vested on 3/31/2013). The date of grant for the options was ten years prior to the expiration date. 25% of the shares underlying the option vest on each of the first, second, third and fourth anniversaries of the date of grant (fully vested on the 4th anniversary of the grant date). The date of grant for the options was ten years prior to the expiration date. 50% of the shares underlying the option vest on each of the first and second anniversaries of the date of grant (fully vested on the 2nd anniversary of the grant date). The date of grant for the options was ten years prior to the expiration date. /s/ Lewis H. Leicher, Attorney-in-Fact for Peter Anevski 2014-08-18